Users Stopping Weight-Loss Medications Regain Pounds Far More Rapidly Compared to People Using Diet and Exercise

New research suggests that people who come off new slimming jabs like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs.

Published data in a major health publication demonstrates that while overweight individuals frequently drop about a fifth of their total mass while using the jabs, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.

"Users purchasing these medications need to be informed of the danger of rapid weight regain when the medication is stopped," stated expert Dr. Susan Jebb.

This pace of regain means a reversion to pre-treatment weight in about 18 months.

Comparing Approaches

The analysis, which reviewed 37 of studies involving thousands of patients, compared the results of these new drugs with older methods.

The team note that individuals who shed pounds through dieting usually have a more gradual creep back—around 0.1 kg a month—after stopping.

Explaining the Rapid Rebound

Nutrition scientists believe the mechanism of the injections is key to understanding the heightened weight return.

The injections mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 levels several times higher than normal could lead to the system to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this medication results in hunger is no longer kept in check, making excessive eating a significant risk."

An Ongoing Issue?

Medical guidelines recommend the injections for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

A number of clinicians argue that, given the significant potential of relapse, the treatment is often life-long.

This view is reinforced by drug manufacturers, who note that the findings "highlight the persistent nature of excess weight," similar to managing conditions like hypertension.

Patient Accounts

People who have come off the jabs report a intense resurgence of cravings.

"It felt as if a switch flipping and I was suddenly extremely hungry," said one woman.

This difficulty is worsened if patients have not adopted sustainable lifestyle or habit modifications during treatment.

Growing Adoption

Survey data suggest that millions of adults in the UK have used these injections in the past year, with desire being substantial.

• Adoption is higher among women than males.
• The 40s and 50s demographic shows the highest usage rates.
• A large proportion obtain the drugs through private prescriptions rather than the NHS.

Finally, clinicians emphasize that while GLP-1 drugs are potent tools for weight loss, they are not a permanent solution and long-term success likely depends on ongoing lifestyle management.